Credit Suisse’s Monte Rosa Therapeutics GLUE Stock Holding History

Credit Suisse’s Portfolio GLUE Stock Details GLUE Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	$110K	Sell
2023 Q4	$113K	Sell
2023 Q3	$313K	Buy
2023 Q2	$368K	Buy
2023 Q1	$262K	Buy
2022 Q4	$212K	Buy
2022 Q3	$181K	Buy
2022 Q2	$98K	Buy